Nonalcoholic Steatohepatitis (NASH) Market by Therapeutics | 2020

1
Nonalcoholic Steatohepatitis (NASH) Market
Opportunity Analysis and Industry Forecast,
2016-2023
Global Opportunity Analysis and Industry
Forecast, 2017-2023
2
Introduction of Nonalcoholic Steatohepatitis
(NASH) Market
The global market is expected to garner 1.6
billion by 2020, registering a CAGR of 25.6
during the period 2014-2020. The high prevalence
of Type II diabetes and obesity, which lead to
NASH and other nonalcoholic fatty liver diseases
(NAFLD), would boost market growth. North
America's heightened focus of NASH research has
resulted in its accounting for nearly half of the
global market. It is also the region with the
maximum occurrences of NASH and other
nonalcoholic fatty liver diseases. Europe ranks
second in terms of the prevalence of NASH. The
number of patients living with the diabetes
worldwide is expected to soar from 371 million in
2012 to 552 million by 2030. This suggests that
by 2030, there will be 3 new cases of diabetes
every 10 seconds. "The rampant growth of diabetes
and obesity has prompted pharmaceutical
manufacturers to seek out novel pharmaceutical
solutions to tap promising potential in NASH,"
states AMR analyst Roshan Deshmukh. "Instrumental
initiatives and increasing clinical trials for
the development of novel NASH therapeutics will
steer its faster commercialization," adds the
analyst.
3
Introduction of Nonalcoholic Steatohepatitis
(NASH) Market
Scope of
the Report
Key Benefits Key Audiences
4
 
Key Benefits

• Various opportunities for non alcoholic fatty
  liver disease therapeutics present in developed
  as well as developing economies are thoroughly
  assessed.
• Substitute treatments and their potential impact
  on NASH therapeutics are strategically quantified
  in the report.
• Opportunities from a business perspective latent
  in the Asia-Pacific region are brought to light.
• Market dimensions of diagnostic techniques used
  in NASH monitoring provide a clear outline of the
  NASH therapeutics research market
• Geography-wise segmentation of clinical trials is
  conducted to provide strategic intelligence to
  the stakeholder.
• Drivers and factors limiting market expansion are
  studied in detail.
• Click to Access Full Summary of Non-alcoholic
  Steatohepatitis Market

5
 
Table of Content (TOC)
Chapter 1 Introduction Chapter 2 Executive
Summary Chapter 3 Market Overview Chapter 4
Market Beyond What To Expect By 2025 Chapter 5
Global Nonalcoholic Steatohepatitis Market By
Drug Types Chapter 6 Global Nonalcoholic
Steatohepatitis Market (Pipeline Drug Analysis)by
Geography, 2013-2020 Chapter 8. Company
Profiles
6
 
Segments Nonalcoholic Steatohepatitis (NASH)
Market
7
 
Segments Nonalcoholic Steatohepatitis (NASH)
Market
8
 
Company Profiles Ceramic Matrix Composites Market
1. Genfit 2. Gilead Science 3. Novo Nordisk 4.
Intercepts Pharmaceuticals 5. Enzo Biochem,
Inc. 6. Raptor Pharmaceutical Corp.
9
Thank You!
For More Details
Thank You Ceramic Matrix Composites Market
Do Enquiry
https//www.alliedmarketresearch.com/nonalcoholic-
steatohepatitis-NASH-market
Follow Us On